The Technical Analyst
iPath Goldman Sachs [BWV]
Exchange: NYSE Sector: Healthcare Industry: Biotechnology
iPath Goldman Sachs Price, Forecast, Insider, Ratings, Fundamentals & Signals
-6.97% $0.180
America/New_York / 21 des 2023 @ 15:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3.41 mill |
| EPS: | -1.080 |
| P/E: | -0.167 |
| Earnings Date: | Mar 08, 2024 |
| SharesOutstanding: | 18.90 mill |
| Avg Daily Volume: | 0.436 mill |
| RATING 2024-01-16 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.167 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.167 | industry: PE 40.47 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.130 - 0.218 ( +/- 25.36%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-12-15 | Schiess Ralph | Sell | 0 | Common Stock |
| 2023-12-15 | Bruhlmann Christian | Sell | 0 | Common Stock |
| 2023-10-04 | Campbell Neil J | Sell | 532 326 | Stock Option |
| 2023-10-04 | Harmon Bruce | Sell | 177 442 | Stock Option |
| 2023-05-31 | Jeremic Vuk | Buy | 6 360 | Common Stock |
| INSIDER POWER |
|---|
| -71.83 |
| Last 40 transactions |
| Buy: 4 886 577 | Sell: 8 258 116 |
Forecast:
01:40 - $0.0900
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.180 (-6.97% ) |
| Volume | 0.520 mill |
| Avg. Vol. | 0.436 mill |
| % of Avg. Vol | 119.46 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BWV
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BWV
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
Latest Press Releases
2023-12-19 07:00:00 - Press Release
Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter To Shareholders
Cincinnati, dec. 19, 2023 (globe newswire) -- onconetix, inc., (nasdaq: bwv) ("onconetix" or the “company”) today issued the following shareholder letter from the company's chief executive officer, dr. neil campbell.
2023-12-18 07:00:00 - Press Release
Blue Water Biotech Acquires Proteomedix As Part Of Transformation To Commercial Stage Oncology Company; Announces Name Change To Onconetix™
Transaction strengthens commercial business with addition of diagnostics product and initial focus on prostate cancer transaction strengthens commercial business with addition of diagnostics product and initial focus on prostate cancer
2023-11-02 07:00:00 - Press Release
Blue Water Biotech Signs Non-binding Term Sheet To Acquire a Commercial Stage Oncology Company
Transaction will advance company's shift in business strategy aligned with life sciences industry expertise of new leadership team transaction will advance company's shift in business strategy aligned with life sciences industry expertise of new leadership team
2023-11-01 07:00:00 - Press Release
Blue Water Biotech Announces It Has Regained Compliance With Nasdaq Listing Rule 5250(c)(1)
Cincinnati, nov. 01, 2023 (globe newswire) -- blue water biotech, inc. (nasdaq: bwv) ("bwb" or the “company”) today announced that it has received a letter from the nasdaq stock market, llc ("nasdaq") stating that the company has regained compliance with the nasdaq stock market, llc listing rule 5250(c)(1) (the "rule").
2023-10-30 07:00:00 - Press Release
Blue Water Biotech Issues Letter To Shareholders
Cincinnati, oct. 30, 2023 (globe newswire) -- blue water biotech, inc. (nasdaq: bwv) ("bwb" or the “company”) today issued the following shareholder letter from the company's chief executive officer dr. neil campbell.
Latest News
2023-06-15 10:47:31 - Zacks Investment Research
Blue Water (BWV) Up on Acquisition of 6 FDA-Approved Drugs
Blue Water (BWV) soars 62% after declaring its deal to purchase six FDA-approved products for $8.5 million. The agreement will help expand the company's portfolio into cardiology and pain management.
2023-05-10 12:15:00 - GlobeNewsWire
Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY
CINCINNATI, May 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biopharmaceutical company developing transformational therapies to address significant global health challenges, today announced that Blue Water management will present at the JMP Securities Life Sciences Conference at the New York Hilton Midtown on Monday, May 15th at 3:30pm EDT.
2023-02-15 06:00:00 - PennyStocks
How to Trade Penny Stocks Online: Short Guide
Here's some tips on how to trade penny stocks online The post How to Trade Penny Stocks Online: Short Guide appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-02-14 12:10:37 - PennyStocks
Penny Stocks To Buy After CPI Report? 3 To Watch Today
2023-01-09 08:30:00 - GlobeNewsWire
Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco
CINCINNATI, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that BWV management will present at the Biotech Showcase 2023 in San Francisco, California, happening during the 41st Annual J.P. Morgan Healthcare Conference. During the presentation, management will provide a corporate overview, recent milestones and execution, and company pipeline updates.
2022-12-01 08:30:00 - GlobeNewsWire
Blue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress West Coast 2022
CINCINNATI, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), today announced that Ali Fattom, Ph.D., will present at the World Vaccine & Immunotherapy Congress West Coast 2022 in San Diego, California on Thursday, December 1, 2022. Dr. Fattom will present an overview and current progress of BWV-201, a live attenuated, intranasally delivered, serotype independent Streptococcus pneumoniae vaccine candidate for the prevention of acute otitis media (“AOM”), pneumococcal pneumonia, and invasive pneumococcal disease.
2022-09-21 08:00:00 - GlobeNewsWire
Blue Water Vaccines to Present at World Vaccine Congress Europe 2022
CINCINNATI, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that the Company will host a roundtable discussion and present at the World Vaccine Congress Europe 2022 in Barcelona, Spain.
2022-08-30 06:00:00 - PennyStocks
Hot Penny Stocks For Your Buy List in September? 3 to Watch
Here's what you need to know about trading penny stocks on August 30th The post Hot Penny Stocks For Your Buy List in September? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-08-24 14:00:00 - GlobeNewsWire
Blue Water Vaccines to Present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom
CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that scientists from its research partner, The University of Oxford, will present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom on Monday, September 5th, 2022.
2022-08-17 16:33:24 - Yahoo Finance
Monkeypox vaccine plans lead to stock jump for Blue Water Vaccines
After announcing that it plans to potentially develop a monkeypox vaccine, Blue Water Vaccines shares are surging.